zokinvy
eigerbio europe limited - lonafarnib - progeria; laminopathies - Önnur meltingarvegi og efnaskipti vörur, - zokinvy is indicated for the treatment of patients 12 months of age and older with a genetically confirmed diagnosis of hutchinson-gilford progeria syndrome or a processing-deficient progeroid laminopathy associated with either a heterozygous lmna mutation with progerin-like protein accumulation or a homozygous or compound heterozygous zmpste24 mutation.
ionsys
incline therapeutics europe ltd - fentanýlhýdróklóríð - verkir, eftir aðgerð - verkjalyf - ionsys er ætlað til meðferðar við bráðum, miðlungsmiklum eða alvarlegum verkjum eftir fullorðna hjá fullorðnum sjúklingum.
anatera stungulyf, lausn 10 %
alcon nordic a/s - fluoresceinum natríum - stungulyf, lausn - 10 %
vigamox (moxifloxacin alcon) augndropar, lausn 5 mg/ml
novartis healthcare a/s - moxifloxacinum hýdróklóríð - augndropar, lausn - 5 mg/ml
vibeden stungulyf, lausn 1 mg/ml
sandoz a/s* - hydroxocobalaminum hýdróklóríð - stungulyf, lausn - 1 mg/ml
mucolysin freyðitafla 600 mg
sandoz a/s* - acetylcysteinum inn - freyðitafla - 600 mg
paracetamol sandoz filmuhúðuð tafla 500 mg
sandoz a/s* - paracetamolum inn - filmuhúðuð tafla - 500 mg
alcaine augndropar, lausn 5 mg/ml
alcon nordic a/s - proxymetacainum hýdróklóríð - augndropar, lausn - 5 mg/ml
atarax filmuhúðuð tafla 25 mg
ucb nordic a/s - hydroxyzinum hýdróklóríð - filmuhúðuð tafla - 25 mg
atarax mixtúra, lausn 2 mg/ml
ucb nordic a/s - hydroxyzinum hýdróklóríð - mixtúra, lausn - 2 mg/ml